Michael McDonald, MD

Dr. Michael McDonald is a distinguished urologist who has dedicated over two decades to clinical excellence at AdventHealth Celebration. Throughout his tenure, he has focused his expertise on the sophisticated management of renal cancer and the treatment of complex, large kidney stones. As a vanguard of surgical innovation, Dr. McDonald has consistently sought to accelerate urological care through the integration of advanced technology. His early identification of histotripsy as a transformative treatment modality a decade ago led to his pivotal involvement in the 2025 FDA IDE trial for kidney cancer, positioning him at the forefront of non-invasive therapeutic research.

In January 2026, Dr. McDonald furthered his commitment to medical progress by founding the Society of Incisionless Surgery (SIS). Serving as the architect of this international organization, he leads a global effort to promote and standardize the next evolution of surgical intervention. Under his leadership, the SIS fosters strategic partnerships with leaders in artificial intelligence and advanced imaging to redefine surgical precision and patient recovery. Beyond his clinical and administrative roles, Dr. McDonald remains a passionate advocate for modernizing healthcare to ensure that the future of surgery is accessible, effective, and entirely incision-free.